Recombinant <i>Saccharomyces cerevisiae</i> EBY100/pYD1-FaeG: a candidate for an oral subunit vaccine against F4+ ETEC infection.

Appl Environ Microbiol · 2025 · PMC11784076 · PMID 39601541

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the extent of cytokine upregulation observed with the EBY100/pYD1-FaeG group was greater than that of the EBY100/pYD1 group, this difference did not reach statistical significance ( Fig. 4F ).

also in 111,027 other papers

a decreasing trendno p-value reported

The results indicated that the expression level of the FaeG protein was relatively higher at 48 h, and it showed a decreasing trend with the extension of expression time ( Fig. 2C and D ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.